📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-08-24 18:24
666 analysed today
666
Today
133,555
All-time analysed
40,122
Positive
6,284
Negative
79,331
Neutral
7,750
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
19 announcements match the current filters (relevance ≥ 5).
Sigachi to Raise Rs 290.40 Cr via 11 Cr Preferential Warrants; EGM on Sep 15
Sigachi Industries has issued an EGM notice for September 15, 2026, to seek shareholder approval for raising up to Rs 290.40 Cr through the preferential allotment of 11.00 crore convertible warrants at an issue price of Rs 26.40 per warrant. Promoter Mr. Amit Raj Sinha will subscribe to 7.50 crore warrants (Rs 198.00 Cr), while non-promoters will take up the remaining 3.50 crore warrants. To accommodate the issuance, the company is also increasing its authorized share capital from Rs 43.00 Cr to Rs 60.00 Cr. The fundraise represents ~24.3% of the company's current market capitalization of Rs 1,197 Cr.
Confidence: HIGH
What changedSigachi has initiated shareholder approval processes to raise Rs 290.40 Cr through convertible warrants and expand authorized capital to Rs 60 Cr.
Why it mattersProvides substantial growth capital (equal to ~61% of current net worth) with high promoter participation to support capex plans and debt management.
Total fundraise value: Rs 290.40 CrFundraise vs Market Cap: ~24.3%Issue price per warrant: Rs 26.40Promoter warrants: 7,50,00,000 unitsAuthorised capital expansion: Rs 43.00 Cr to Rs 60.00 Cr
📅 Short termShareholders will vote on the resolution by September 15, 2026. The issue price of Rs 26.40 represents a modest discount to the current market price of Rs 30.5.
📈 Long termThe capital injection will strengthen the balance sheet for upcoming expansions in MCC and CCS product lines, though conversion of warrants will result in equity dilution over up to 18 months.
⚠ Risk flags
- Equity dilution of up to 11 crore shares upon warrant conversion
- Timely deployment and execution of capital into return-accretive assets
Key Highlights
Preferential issue of up to 11.00 crore convertible warrants at Rs 26.40 each, aggregating up to Rs 290.40 Cr
Promoter Amit Raj Sinha to receive 7.50 crore warrants (~68.2% of total issue) worth Rs 198.00 Cr
Authorised share capital to be increased from Rs 43.00 Cr to Rs 60.00 Cr (face value Re 1 each)
EGM scheduled on September 15, 2026, with e-voting cut-off date fixed as September 8, 2026
👀 What to Watch
Track the voting outcome of the September 15, 2026 EGM and subsequent in-principle exchange approvals and warrant application money inflows.
Sigachi Board approves ₹290.4 Cr warrant issue; promoter stake to rise to 43.73%
Sigachi Industries has approved the issuance of up to 11.00 crore convertible warrants at an issue price of ₹26.40 per warrant on a preferential basis, raising up to ₹290.40 crore. The promoter group will be allotted 7.50 crore warrants (₹198.00 crore), increasing the promoter holding from 36.69% to 43.73% upon full conversion. The fundraise represents ~24.6% of current market cap (₹1,180 crore) and ~61.7% of TTM revenue (₹471 crore). The company has also appointed RSM Astute Consulting Pvt Ltd as internal auditors and scheduled an EGM on September 15, 2026 to seek shareholder approval.
Confidence: HIGH
What changedSigachi approved a ₹290.40 crore preferential warrant issue, expanded authorized share capital to ₹60 crore, and replaced internal auditors PRSV & Co. with RSM Astute Consulting.
Why it mattersThe substantial promoter participation (₹198 crore) signals strong insider confidence and strengthens the balance sheet to support ongoing capacity expansions in MCC and APIs, despite potential equity dilution.
Total Fundraise Amount: ₹290.40 CrFundraise vs Market Cap: ~24.6%Fundraise vs TTM Revenue: ~61.7%Warrant Issue Price: ₹26.40Post-Conversion Promoter Stake: 43.73%EGM Date: September 15, 2026
📅 Short termMarket reaction is likely to be positive given significant promoter commitment, though the issue price of ₹26.40 represents a modest ~12% discount to the prevailing market price of ₹30.1.
📈 Long termProvides necessary growth capital to fund capacity expansions (targeting 33,700 MTPA) and API scale-up, strengthening debt-servicing capability and balance sheet leverage.
⚠ Risk flags
- Equity dilution of ~25% upon full conversion of warrants within 18 months
- Variation in initial public issue object clause flagged for shareholder approval
Key Highlights
Issuance of up to 11,00,00,000 convertible warrants at ₹26.40 each, raising up to ₹290.40 crore
Promoter Amit Raj Sinha to receive 7.50 crore warrants (68.18% of the issue), raising promoter stake to 43.73%
Authorised share capital proposed to be increased from ₹43.00 crore to ₹60.00 crore
Conversion tenure of up to 18 months from allotment date; Care Ratings appointed as Monitoring Agency
Extra-Ordinary General Meeting (EGM) scheduled for September 15, 2026 to vote on the proposal
👀 What to Watch
Track shareholder voting results at the September 15, 2026 EGM and monitor subsequent 25% upfront warrant subscription inflows followed by capex deployment updates for Dahej expansion.
Sigachi Board Approves ₹290.4 Cr Convertible Warrant Issue at ₹26.40/Share
Sigachi Industries has approved a preferential issue of up to 11.00 crore convertible warrants at an issue price of ₹26.40 per warrant, raising up to ₹290.40 crore. Promoter Amit Raj Sinha is subscribing to 7.50 crore warrants (₹198 crore), which will increase total promoter shareholding from 36.69% to 43.73% post-full conversion. The proposed fundraise equals ~24.6% of current market cap (₹1,180 crore) and ~61.6% of TTM revenue (₹471 crore). An EGM is scheduled on September 15, 2026 to seek shareholder approval.
Confidence: HIGH
What changedThe board approved a ₹290.40 crore warrant issue primarily anchored by the promoter, alongside an increase in authorized capital and change of internal auditors to RSM Astute Consulting.
Why it mattersA significant promoter cash commitment (₹198 crore) increases promoter skin in the game (to 43.73%) and provides growth capital, though it will dilute equity by ~25% upon complete conversion over the 18-month tenure.
Total warrants issue size: 11,00,00,000Issue price per warrant: Rs. 26.40Total fundraise value: Rs. 290.40 crFundraise vs Market Cap: ~24.6%Fundraise vs TTM Revenue: ~61.6%Post-issue Promoter Holding: 43.73%
📅 Short termPositive sentiment likely due to heavy promoter participation at ₹26.40 (close to current market price), pending EGM approval on September 15, 2026.
📈 Long termBolsters the balance sheet for ongoing capacity expansions (Dahej SEZ, Croscarmellose Sodium line, and API scaling) while materially increasing promoter commitment.
⚠ Risk flags
- Equity dilution of ~25% across 18 months upon full conversion
- Variation/deviation in the object clause of the previous IPO issue to be approved by shareholders
Key Highlights
Preferential issuance of up to 11,00,00,000 convertible warrants at ₹26.40 each, raising ~₹290.40 crore
Promoter Amit Raj Sinha allotted 7,50,00,000 warrants (68.2% of total issue), taking promoter stake to 43.73% post-conversion
42 non-promoter investors to be allotted the remaining 3,50,00,000 warrants
Authorised share capital to be increased from ₹43.00 crore to ₹60.00 crore
EGM convened for September 15, 2026; Care Ratings appointed as Monitoring Agency
👀 What to Watch
Track the voting outcome of the EGM on September 15, 2026, and look for clear disclosures on the deployment schedule for expansion or debt reduction in the EGM notice.
Sigachi Q1 FY27 Concall: Reaffirms FY27 Guidance of ₹650-675 Cr; MCC Realization at ₹241/kg
Sigachi Industries released its Q1 FY27 earnings call transcript, reaffirming its full-year FY27 revenue guidance of ₹650-675 crore and full-year EBITDA margin target of ~18%. For Q1 FY27, revenue stood at ₹121.27 crore with EBITDA at ₹16.5 crore (13.6% margin) and PAT at ₹8.14 crore. MCC average realization improved to ₹241.36 per kg from ₹216 per kg in Q4. The company's 12,000 MTPA MCC capacity expansion at Dahej-2 is targeted for commissioning by Q2 FY28, raising total capacity to 30,000 MTPA.
Confidence: HIGH
What changedSubmission of the verbatim transcript for the Q1 FY27 earnings conference call held on August 13, 2026.
Why it mattersProvides detailed management commentary on pricing power, product mix ramp-up across APIs and excipients, and project timelines for regaining lost market share.
FY27 Revenue Guidance: ₹650 - 675 crQ1 FY27 Revenue: ₹121.27 crQ1 FY27 EBITDA Margin: 13.6%MCC Realization (Q1 vs Q4): ₹241.36/kg vs ₹216/kgTargeted Total MCC Capacity: 30,000 MTPA by Q2 FY28
📅 Short termNeutral; operational performance is steady, but achieving full-year targets will require a steep step-up in quarterly execution during H2 FY27.
📈 Long termStructural growth depends on the timely commercialization of the 12,000 MTPA Dahej expansion and 1,800 MTPA CCS capacity to recapture market share and expand high-margin API sales.
⚠ Risk flags
- Guidance execution risk given the required run-rate step-up from ₹121 cr to >₹165 cr per quarter
- Dependency on imported wood pulp raw material prices
- Loss of customer wallet share due to past capacity shortfalls
Key Highlights
Reaffirmed FY27 revenue guidance of ₹650-675 crore, expecting significant ramp-up in the second half
Reported Q1 FY27 revenue of ₹121.27 crore, EBITDA of ₹16.50 crore (13.6% margin), and PAT of ₹8.14 crore
Average MCC realization increased to ₹241.36/kg in Q1 from ₹216.00/kg in Q4
Segment revenue contribution: MCC ₹82.74 crore, API ₹21.68 crore, and O&M ₹13.06 crore
12,000 MTPA MCC Dahej-2 expansion on track for Q2 FY28 commissioning, scaling total excipient capacity to 30,000 MTPA
👀 What to Watch
Track whether quarterly revenue scales toward the required ~₹165-175 crore run rate in H2 FY27 to achieve the ₹650-675 crore annual guidance, alongside the commissioning timeline of the Dahej-2 and CCS facilities.
Sigachi Forfeits Rs 22.87 Cr on Lapsed Warrants; Reports Q1 PAT of Rs 8.14 Cr
Sigachi Industries reported a consolidated PAT of Rs 8.14 Cr for Q1 FY27, recovering from a heavy loss in the prior year's quarter. The company forfeited Rs 22.87 Cr as 3.50 Cr convertible warrants (including those held by promoters) lapsed without being exercised. The board also re-appointed two Independent Directors for second five-year terms and confirmed that Rs 32.30 Cr of IPO proceeds remain unutilized for the Dahej CCS project.
Confidence: HIGH
What changedThe company's capital structure has been finalized regarding the 2023 warrant issue with a portion being forfeited, and the board has secured leadership continuity by re-appointing two independent directors.
Why it mattersThe forfeiture of warrants by promoters and investors suggests a hesitation to infuse the remaining 75% capital (approx. Rs 68 Cr) at the strike price of Rs 26.1, although the forfeited 25% provides a one-time boost to the company's reserves.
Consolidated Revenue (Q1 FY27): Rs 121.27 CrConsolidated PAT (Q1 FY27): Rs 8.14 CrAmount Forfeited: Rs 22.87 CrForfeited Amount vs Net Worth: ~4.8%Unutilized IPO Proceeds: Rs 32.30 Cr
📅 Short termThe stock may see mixed sentiment as the market weighs the steadying earnings against the signal sent by promoters allowing their warrants to lapse.
📈 Long termLong-term growth depends on the successful commissioning of the CCS project and the planned expansion to 33,700 MTPA capacity, which are critical for re-rating the business.
⚠ Risk flags
- Promoter warrants lapsed (indicates potential capital allocation shift)
- High dependency on imported wood pulp
- Delayed utilization of IPO proceeds for the CCS project
Key Highlights
Consolidated Revenue for Q1 FY27 stood at Rs 121.27 Cr, compared to Rs 128.25 Cr in the same quarter last year.
Net Profit reached Rs 8.14 Cr, a significant recovery from the Rs 100.97 Cr loss in Q1 FY26 which was impacted by exceptional items.
Forfeiture of Rs 22.87 Cr (25% upfront consideration) due to the lapse of 3,50,57,990 convertible warrants.
Promoter-linked entities including Amit Raj Sinha (HUF) and Swati Sinha were among those whose warrants lapsed.
Rs 32.30 Cr in IPO proceeds remains unutilized, specifically earmarked for the Croscarmellose Sodium (CCS) project at Dahej.
👀 What to Watch
Investors should monitor the utilization of the remaining Rs 32.30 Cr IPO funds for the CCS project and observe if the company can maintain its current operating margins without the additional capital from the lapsed warrants.
Sigachi Q1 PAT at ₹8.14 Cr; Forfeits ₹22.88 Cr as 3.5 Cr Warrants Lapse
Sigachi Industries reported a consolidated PAT of ₹8.14 Cr for Q1 FY27, a recovery from the ₹100.97 Cr loss in Q1 FY26 which was heavily impacted by a fire incident. Consolidated revenue saw a slight decline of 5.4% YoY to ₹121.27 Cr. A major development is the forfeiture of ₹22.88 Cr (25% upfront consideration) as 3.5 crore convertible warrants, including those held by promoters, lapsed without being exercised. The company continues to hold ₹32.30 Cr in unutilized IPO proceeds specifically for its CCS project at Dahej.
Confidence: HIGH
What changedThe company reported its Q1 FY27 financial results and officially forfeited ₹22.88 Cr in capital after several warrant holders, including promoters, failed to exercise their conversion options.
Why it mattersThe earnings show a return to operational normalcy after the major fire loss in FY26. However, the warrant forfeiture by promoters suggests a choice not to infuse further equity at the previously agreed price of ₹26.1 per share.
Consolidated Revenue (Q1 FY27): ₹121.27 CrConsolidated PAT (Q1 FY27): ₹8.14 CrAmount Forfeited: ₹22.88 CrForfeited Amount vs Net Worth: ~4.8%Warrants Lapsed: 3,50,57,990 unitsWarrant Exercise Price: ₹26.1
📅 Short termThe recovery in PAT is a positive sign, but the slight YoY revenue dip and the lapse of promoter warrants may lead to a cautious market reaction in the near term.
📈 Long termThe long-term outlook depends on the successful commercialization of the CCS facility and reaching the targeted 33,700 MTPA MCC capacity to drive the projected 30% growth rate.
⚠ Risk flags
- Promoter warrant lapse (potential lack of immediate conviction)
- High dependency on imported wood pulp (100% imported)
- Slight YoY decline in consolidated revenue
Key Highlights
Consolidated Revenue for Q1 FY27 stood at ₹121.27 Cr, down 5.4% from ₹128.25 Cr in Q1 FY26.
Consolidated PAT turned positive at ₹8.14 Cr compared to a loss of ₹100.97 Cr in the previous year's quarter.
Forfeited ₹22.88 Cr following the lapse of 3,50,57,990 convertible warrants that were not exercised within the 18-month window.
Promoter-linked entities (Amit Raj Sinha HUF, Swati Sinha) were among those whose warrants lapsed, representing a significant portion of the forfeited amount.
IPO proceeds of ₹32.30 Cr remain unutilized for the Croscarmellose Sodium (CCS) project at Dahej, while other expansion projects are fully funded.
👀 What to Watch
Investors should monitor the execution timeline of the CCS project at Dahej and the stabilization of margins following the previous year's fire disruptions. The lapse of warrants by promoters at an exercise price of ₹26.1 (near current market price) warrants observation regarding management's short-term valuation outlook.
Sigachi Q1 FY27: PAT Returns to Rs 8.2 Cr; EBITDA Margin Improves to 13.6%
Sigachi Industries reported a consolidated revenue of Rs 121.3 Cr for Q1 FY27, representing a 5.4% YoY decline but remaining stable QoQ. The company successfully returned to profitability with a PAT of Rs 8.2 Cr, recovering from the heavy exceptional losses incurred in FY26 due to a fire incident. EBITDA margins showed a sequential improvement of 97 bps to 13.60%. The core Microcrystalline Cellulose (MCC) business continues to dominate, contributing 80% of the total revenue mix.
Confidence: HIGH
What changedThe company has transitioned back to profitability (PAT Rs 8.2 Cr) following a volatile FY26 marked by a major fire incident and exceptional write-offs.
Why it mattersThis turnaround indicates operational stability and a successful shift of production to other units; the expansion plans suggest a significant capacity increase that could drive future volume growth.
Q1 FY27 Revenue: Rs 121.3 CrQ1 FY27 PAT: Rs 8.2 CrEBITDA Margin: 13.60%Planned Capacity Expansion: 12,000 MTPAAPI Revenue Contribution: 7%Revenue vs TTM Revenue: ~25.4%
📅 Short termThe return to profitability and sequential margin improvement are likely to be viewed positively by the market in the coming weeks.
📈 Long termThe structural shift toward a diversified Pharma platform (MCC + API) and the 55% capacity expansion at Dahej provide a clear growth roadmap for the next 2-3 years.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- 100% dependency on imported wood pulp for raw materials
- Concentration risk with MCC contributing 80% of revenue
- Execution risk for the Dahej expansion project
Key Highlights
Revenue from operations stood at Rs 121.3 Cr, a slight 0.49% decrease compared to the previous quarter.
EBITDA margin improved to 13.60% from 12.63% in Q4 FY26, driven by operational efficiencies.
Microcrystalline Cellulose (MCC) remains the primary revenue driver at 80%, followed by O&M at 10% and API at 7%.
The company is progressing toward a total capacity of 33,700 MTPA, adding 12,000 MTPA at the Dahej SEZ.
API R&D center in Hyderabad is now fully operational to support the newly acquired Trimax Bio Sciences portfolio.
👀 What to Watch
Investors should monitor the execution timeline for the 12,000 MTPA Dahej expansion and the margin trajectory of the API segment as it scales. The recovery from FY26's exceptional losses is a key milestone to track in upcoming quarters.
Sigachi Q1 Net Profit at ₹8.14 Cr; ₹22.88 Cr Forfeited as 3.5 Cr Warrants Lapse
Sigachi Industries reported a consolidated Q1 FY27 net profit of ₹8.14 Cr, recovering from a ₹100.97 Cr loss in the same quarter last year which was impacted by a major fire. Revenue for the quarter stood at ₹121.27 Cr, showing a 5.4% decline YoY but remaining stable sequentially. A key development is the forfeiture of ₹22.88 Cr as 3.50 crore warrants, including those held by promoters, were not exercised within the 18-month deadline. The company still holds ₹32.30 Cr in unutilized IPO proceeds earmarked for its CCS project at Dahej.
Confidence: HIGH
What changedThe company has returned to normalized profitability after the exceptional fire-related losses of the previous year, and potential equity dilution has been reduced due to the lapse of 3.5 crore warrants.
Why it mattersThe lapse of warrants by promoters despite the price being near the market rate suggests a cautious approach to capital infusion. The forfeited amount will move to capital reserves, providing a small non-operational boost to the balance sheet.
Q1 Consolidated Revenue: ₹121.27 CrQ1 Consolidated Net Profit: ₹8.14 CrAmount Forfeited: ₹22.88 CrWarrant Exercise Price: ₹26.1Unspent IPO Capex: ₹32.30 Cr
📅 Short termThe stock may see neutral to slightly cautious sentiment as the market processes the stable earnings against the backdrop of promoters letting their warrants lapse.
📈 Long termLong-term growth is tied to the expansion of MCC capacity to 33,700 MTPA and the successful commercialization of the CCS product line.
⚠ Risk flags
- Promoter warrants lapsed (indicates potential liquidity or valuation caution)
- 100% dependency on imported wood pulp
- Concentrated supplier base
Key Highlights
Consolidated Net Profit of ₹8.14 Cr in Q1 FY27 vs a loss of ₹100.97 Cr in Q1 FY26.
Forfeiture of ₹22.88 Cr representing the 25% upfront consideration for 3,50,57,990 lapsed warrants.
Promoter-linked entities, including Amit Raj Sinha (HUF), were among those who allowed warrants to lapse.
Warrant exercise price was ₹26.1, which is very close to the current market price of ₹27.2.
₹32.30 Cr of IPO proceeds remain unutilized for the Croscarmellose Sodium (CCS) project at Dahej.
👀 What to Watch
Investors should monitor the execution timeline of the CCS project at Dahej and the impact of the warrant forfeiture on the company's capital reserves and future fund-raising plans.
Sigachi Q4 FY26: PAT at ₹7.6 Cr; FY27 Revenue Guidance Set at ₹650-675 Cr
Sigachi Industries reported a stable Q4 FY26 with operating income of ₹121.89 crores and a PAT of ₹7.6 crores. The company provided strong guidance for FY27, targeting revenue between ₹650-675 crores and EBITDA margins of 18-20%. Growth is expected to be driven by capacity expansions at Dahej and Jhagadia, with total MCC capacity reaching 30,000 MTPA by Q4 FY27. Management is also focusing on high-value excipients and the API segment, which currently operates at 65-70% utilization.
Key Highlights
Reported Q4 FY26 revenue of ₹121.89 crores with EBITDA margins at 12.63%.
FY27 revenue guidance of ₹650-675 crores implies a significant growth trajectory of approximately 35%.
MCC capacity to expand to 30,000 MTPA by Q4 FY27 with the addition of 12,000 MTPA at Dahej.
API segment contributed ₹17.06 crores in Q4 with a current utilization rate of 65-70%.
Expects EBITDA margins to recover to 18-20% in FY27 supported by an improved product mix.
👀 What to Watch
Investors should monitor the timely commissioning of the Dahej expansion and the recovery of EBITDA margins toward the 18-20% target. The stock may see positive momentum if insurance claims are settled and capacity ramp-up proceeds as guided.
Sigachi Q4 FY26: PAT Rebounds to ₹76 Mn; Targets ₹6,500-6,750 Mn Revenue in FY27
Sigachi Industries reported a recovery in Q4 FY26 with revenue of ₹1,219 Mn, up 4.01% QoQ, and a significant PAT rebound to ₹76 Mn from a near-zero base in Q3. However, the full year FY26 was impacted by a massive ₹1,182 Mn exceptional loss, resulting in a net annual loss of ₹828 Mn. The company has provided optimistic FY27 guidance, targeting revenue of ₹6,500-6,750 Mn and EBITDA margins of 18-20%, supported by the upcoming 12,000 MTPA capacity expansion at Dahej-2.
Key Highlights
Q4 FY26 EBITDA margins improved by 777 bps QoQ to 12.63%, though still down from 22.31% YoY.
Full-year FY26 revenue declined 4.5% YoY to ₹4,778 Mn, with EBITDA falling 52% to ₹537 Mn.
Exceptional items of ₹1,182 Mn led to a consolidated net loss of ₹828 Mn for FY26 compared to a ₹705 Mn profit in FY25.
Dahej-2 expansion is on track to increase total MCC capacity to 30,000 MTPA by Q4 FY27.
Management guidance for FY27 projects a significant recovery with revenue targets up to ₹6,750 Mn and improved margins.
👀 What to Watch
Investors should focus on the company's ability to achieve its 18-20% EBITDA margin guidance in FY27 and the timely commissioning of the Dahej-2 facility. While Q4 shows signs of recovery, the volatility in margins and the impact of the FY26 exceptional loss warrant a cautious approach until growth stabilizes.
Sigachi Industries Reports FY26 Net Loss of ₹79.5 Cr Due to Fire Accident; Declares ₹0.10 Dividend
Sigachi Industries reported a significant standalone net loss of ₹79.55 crore for FY26, a sharp reversal from a profit of ₹47.67 crore in FY25. This loss is primarily attributed to a massive exceptional item of ₹118.21 crore following a tragic fire accident at its Hyderabad plant that resulted in 54 fatalities and property damage. Annual revenue also saw a decline of 7% YoY to ₹379.04 crore. Despite the financial setback, the company recommended a final dividend of ₹0.10 per share and is in the process of filing insurance claims which have not yet been accounted for.
Key Highlights
Standalone revenue from operations for FY26 decreased to ₹379.04 crore from ₹407.83 crore in FY25.
Reported a massive exceptional loss of ₹118.21 crore due to a fire accident at the Pashamylaram plant on June 30, 2025.
The fire accident resulted in the loss of 54 team members and significant damage to property, plant, and equipment.
Net loss for the full year stood at ₹79.55 crore compared to a profit of ₹47.67 crore in the previous year.
Board recommended a final dividend of Re. 0.10 per share, subject to shareholder approval.
👀 What to Watch
Investors should exercise caution as the company navigates the aftermath of the fire accident and operational disruptions. Monitor updates regarding the final insurance claim settlement and the timeline for full restoration of the Hyderabad plant's capacity.
Sigachi Industries Credit Rating Downgraded to CARE BBB; Outlook Remains Negative
CARE Ratings has downgraded Sigachi Industries' long-term facilities and NCDs from BBB+ to BBB following a sharp decline in operating margins to 5.25% in Q3FY26. The company reported a significant net loss of ₹90.46 crore for the quarter, impacted by ₹116.35 crore in exceptional provisions related to a fatal fire incident at its Hyderabad plant. Liquidity is currently strained due to delayed insurance claims of ₹51 crore and increased working capital requirements. Additionally, the promoter group has seen a decline in shareholding due to the invocation of pledged shares, signaling financial leverage concerns.
Key Highlights
Long-term credit rating downgraded to CARE BBB from CARE BBB+; remains on Rating Watch with Negative Implications.
Operating margins collapsed to 5.25% in Q3FY26 compared to 24.89% in Q3FY25 due to higher costs and lower yields.
Reported a net loss of ₹90.46 crore in Q3FY26 after accounting for ₹116.35 crore in fire-related compensation and asset losses.
Promoter shareholding decreased recently due to multiple instances of pledged share invocations and open-market sales.
Company is raising ₹125 crore through NCDs to fund a ₹493 crore expansion plan and bridge liquidity gaps.
👀 What to Watch
Investors should remain cautious as the downgrade reflects deteriorating financial health, high leverage, and uncertainty regarding the ongoing fire investigation. It is advisable to wait for signs of margin recovery and successful insurance claim realization before making further commitments.
Sigachi Q3 FY26: Revenue at ₹117.2 Cr, EBITDA Margin Drops to 4.6% Post-Fire Impact
Sigachi Industries reported a total operating income of INR 117.2 crores for Q3 FY26, but faced significant margin pressure with EBITDA falling to INR 5.7 crores (4.6% margin). The company recorded a marginal net loss of INR 0.02 crores, primarily due to the operational impact and cost redistribution following a fire accident at its Hyderabad unit. Management remains optimistic about recovery, targeting a total cellulose-based excipient capacity of 30,000 MTPA by Q3 FY27. Despite current headwinds, demand for Microcrystalline Cellulose (MCC) remains strong with exports accounting for 62% of production.
Key Highlights
Reported Q3 FY26 operating income of INR 117.2 crores with a marginal net loss of INR 0.02 crores.
EBITDA margin compressed to 4.6% due to overhead redistribution and higher logistics costs post-Hyderabad fire.
MCC capacity expansion of 12,000 MTPA at Dahej is on track for commissioning in Q3 FY27, taking total capacity to 30,000 MTPA.
Current cellulose-based excipient capacity stands at 18,000 MTPA with 62% of production exported.
O&M and API segments contributed INR 13.35 crores and INR 14.13 crores respectively to the quarterly revenue.
👀 What to Watch
Investors should monitor the progress of the Dahej expansion and the stabilization of margins as the company moves past the one-time costs associated with the Hyderabad incident. The stock may remain under pressure until EBITDA margins return to the historical 20% plus range.
Sigachi Industries Q3 FY26 Revenue Falls 16% YoY; PAT Slumps to Near Zero
Sigachi Industries reported a weak Q3 FY26 with revenue declining 15.92% YoY to ₹1,172 Mn. Profitability was severely hit as EBITDA plummeted 82.83% YoY to ₹57 Mn, with margins contracting from 23.82% to 4.86%. The company recorded a marginal net loss of ₹0.16 Mn for the quarter and a significant ₹905 Mn loss for 9M FY26, largely due to ₹1,171 Mn in exceptional items. Despite the financial downturn, the company is fast-tracking its MCC capacity expansion to 30,000 MTPA.
Key Highlights
Revenue from operations decreased 15.92% YoY to ₹1,172 Mn in Q3 FY26.
EBITDA margins saw a massive contraction of 1,896 bps YoY, falling to 4.86%.
9M FY26 performance was marred by a ₹1,171 Mn exceptional item, leading to a net loss of ₹905 Mn.
Capacity expansion of 12,000 MTPA at Dahej-2 is being fast-tracked to reach a total capacity of 30,000 MTPA.
The company maintains a healthy balance sheet with a Net Debt to Equity ratio of 0.04 as of FY25.
👀 What to Watch
Investors should be cautious given the sharp decline in operational margins and the impact of large exceptional losses. While the capacity expansion offers long-term growth potential, the immediate focus should be on the company's ability to restore EBITDA margins to historical levels.
Sigachi Industries Q3 Net Profit Slumps to ₹0.20 Cr; Revenue Down 16% YoY
Sigachi Industries reported a weak Q3 FY26 with consolidated revenue declining 16% YoY to ₹117.21 crore. Net profit attributable to shareholders plummeted to ₹0.20 crore from ₹21.35 crore in the same period last year, reflecting severe margin pressure. The company's performance continues to be overshadowed by a massive ₹117.08 crore exceptional loss recorded in the nine-month period due to a major fire at its Hyderabad plant. While revenue grew 6% on a sequential (QoQ) basis, the bottom line remains strained as insurance claims for the fire damage are yet to be recognized in the financial statements.
Key Highlights
Consolidated Revenue from operations fell 15.9% YoY to ₹117.21 crore in Q3 FY26.
Net Profit attributable to shareholders crashed to ₹0.20 crore compared to ₹21.35 crore in Q3 FY25.
Total 9-month consolidated loss stands at ₹90.45 crore, primarily due to a ₹117.08 crore exceptional item from a fire accident.
Employee benefit expenses increased significantly to ₹23.68 crore from ₹19.46 crore YoY.
Insurance claims for the fire accident at the Hyderabad plant are pending and have not been accounted for as income yet.
👀 What to Watch
Investors should exercise caution as the company faces significant operational headwinds and profit erosion following the Hyderabad plant fire. The stock's recovery depends on the successful settlement of insurance claims and the scaling up of its new API and MCC expansion projects.
Sigachi Industries MD & CEO Amit Raj Sinha Granted Bail in 2025 Incident Case
The Hon’ble High Court of Telangana has granted bail to Sigachi Industries' MD & CEO, Amit Raj Sinha, in relation to legal proceedings from an industrial incident on June 30, 2025. This incident involved fatalities and injuries, leading to a period of significant legal and operational strain for the company. While the CEO's release may restore some leadership stability, the company continues to face ongoing judicial processes and investigations. Sigachi has committed to enhancing safety protocols across its units to prevent future occurrences.
Key Highlights
Telangana High Court granted bail to MD & CEO Amit Raj Sinha on February 4, 2026.
Legal matter pertains to a tragic industrial incident that occurred on June 30, 2025.
Company is cooperating with investigating authorities and the judicial process.
Management is focusing on strengthening safety systems and practices across all operations.
👀 What to Watch
Investors should monitor the final outcome of the legal proceedings and any potential financial penalties or regulatory impact on the company's manufacturing licenses. While the CEO's bail is a short-term relief for management stability, the long-term focus should be on the company's improved safety compliance.
Sigachi Achieves R&D Milestone in Cystic Fibrosis APIs; ₹250 Cr Annual Revenue Potential
Sigachi Industries has successfully advanced a new combination of Cystic Fibrosis (CF) Active Pharmaceutical Ingredients (APIs), including Vanzacaftor, Tezacaftor, and Deutivacaftor. This development targets a global CF therapeutics market valued at over USD 10 billion, characterized by high entry barriers and strong pricing resilience. The company estimates an annual revenue potential of approximately ₹250 crore from this portfolio, with commercialization expected to commence in Q4 FY 2026–27. Long-term revenue visibility is supported by innovator patent protection for Vanzacaftor extending until 2039.
Key Highlights
Successful development of high-value CF API combination: Vanzacaftor, Tezacaftor, and Deutivacaftor
Estimated annual revenue potential of ~₹250 crore starting from Q4 FY 2026–27
Targets a global cystic fibrosis therapeutics market exceeding USD 10 billion
Innovator patent protection for Vanzacaftor extends until 2039, ensuring long-term opportunity
Strategic shift towards complex specialty APIs with high entry barriers and limited competition
👀 What to Watch
Investors should view this as a significant move towards higher-margin specialty APIs, though the financial impact is slated for late FY27. Monitor for updates on strategic collaborations with formulation innovators which will be crucial for commercializing this pipeline.
Sigachi MD & CEO Amit Raj Sinha Remanded Over June 2025 Fire Incident Investigation
Sigachi Industries' MD & CEO, Amit Raj Sinha, was remanded on December 27, 2025, in connection with an ongoing investigation into a fire incident at the company's Hyderabad unit that occurred on June 30, 2025. To ensure business continuity, the company has appointed Deputy Group CEO Lijo Stephen Chacko to oversee operations in the interim. This development introduces significant leadership uncertainty and potential legal risks for the company following the industrial accident earlier in the year. Investors should be wary of the impact on corporate governance and potential regulatory repercussions.
Key Highlights
MD & CEO Amit Raj Sinha remanded on December 27, 2025, regarding the Pashamylaram unit fire.
The fire incident at the Hyderabad facility occurred on June 30, 2025, and is under active investigation.
Deputy Group CEO Lijo Stephen Chacko has been tasked with overseeing interim operations.
The company maintains that day-to-day activities and operational continuity are being managed.
👀 What to Watch
Investors should adopt a cautious approach as the detention of a top executive can lead to leadership instability and reputational risks. Monitor further legal updates and the company's ability to maintain operational performance under interim management.
Sigachi Industries Credit Rating Downgraded to CARE BBB+; Negative Watch Continues
CARE Ratings has downgraded Sigachi Industries' long-term rating from CARE A- to CARE BBB+ following a devastating fire at its Hyderabad facility in June 2025. The incident destroyed 30% of the company's capacity (6,400 MTPA), leading to a significant H1FY26 net loss of ₹90.44 crore due to ₹116.35 crore in exceptional provisions for compensation and asset loss. To manage liquidity and fund a ₹493 crore capex plan, the company is raising ₹125 crore through NCDs while awaiting ₹51 crore in insurance claims. The rating remains on 'Rating Watch with Negative Implications' pending the outcome of government investigations and final compensation payouts.
Key Highlights
Long-term bank facilities downgraded to CARE BBB+ from CARE A- and Short-term to CARE A3+ from CARE A2.
Exceptional provision of ₹116.35 crore created in H1FY26 for fire-related compensation and asset loss.
Installed capacity dropped from 21,700 MTPA to 15,300 MTPA after the Hyderabad plant destruction.
Company plans to raise ₹125 crore via NCDs to bridge liquidity gaps and fund a ₹493 crore multi-year capex plan.
Insurance claim of ₹51 crore for plant and machinery loss expected in tranches by Q4FY26 or Q1FY27.
👀 What to Watch
Investors should exercise caution as the 'Negative Watch' indicates potential for further downgrades depending on legal outcomes and insurance recovery timelines. Monitor the company's ability to successfully ramp up Gujarat capacity to 18,000 MTPA to offset production losses.
